Glucotrack announces successful completion of its first human clinical study of continuous blood glucose monitor

The study met its primary endpoint with no procedure or device related serious adverse events reported the study met its primary endpoint with no procedure or device related serious adverse events reported

GCTK Ratings Summary

GCTK Quant Ranking